A fatal yellow fever virus infection in China: description and lessons

Emerging Microbes and Infections

Volumn 5, Issue 1, 2016, Pages 1-8

  Chen, Zhihai ^a   Liu, Lin ^b   Lv, Yanning ^b   Zhang, Wei ^a   Li, Jiandong ^b   Zhang, Yi ^b   Di, Tian ^a   Zhang, Shuo ^b   Liu, Jingyuan ^a   Li, Jie ^b   Qu, Jing ^b   Hua, Wenhao ^a   Li, Chuan ^b   Wang, Peng ^a   Zhang, Quanfu ^b   Xu, Yanli ^a   Jiang, Rongmeng ^a   Wang, Qin ^b   Chen, Lijuan ^b   Wang, Shiwen ^b   Pang, Xinghuo ^b   Liang, Mifang ^b   Ma, Xuejun ^b   Li, Xingwang ^a   Wang, Quanyi ^b   Zhang, Fujie ^a   Li, Dexin ^b   more..

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

clinical investigation; genome sequence; imported case; molecular investigation; yellow fever

Indexed keywords

VIRUS RNA;

ADULT; ANGOLA; ANIMAL; BLOOD; CASE REPORT; CHINA; CHLOROCEBUS AETHIOPS; DNA SEQUENCE; EPIDEMIC; EPIDEMIOLOGY; FATALITY; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; LIVER; MALE; MULTIPLE ORGAN FAILURE; NUCLEOTIDE SEQUENCE; OLIGURIA; PATHOLOGY; TRAVEL; VERO CELL LINE; VIROLOGY; VIRUS GENOME; YELLOW FEVER; YELLOW FEVER VIRUS;

ADULT; ANGOLA; ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; CHINA; DISEASE OUTBREAKS; FATAL OUTCOME; GENOME, VIRAL; GENOTYPE; HUMANS; LIVER; MALE; MULTIPLE ORGAN FAILURE; OLIGURIA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TRAVEL; VERO CELLS; YELLOW FEVER; YELLOW FEVER VIRUS;

EID: 85011601464     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/emi.2016.89     Document Type: Article

References (25)

1. Monath TP.Yellow fever: an update.Lancet Infect Dis2001; 1:11–20.
2. World Health OrganizationYellow fever (Updated March 2016). Geneva: WHO, 2016. Available athttp://www.who.int/mediacentre/factsheets/fs100/en/(accessed on 24 March 2016).
3. Theiler M,Smith. HH.The use of yellow fever modified by in vitro cultivation for human immunization.J Exp Med1937; 65:787–800.
4. World Health OrganizationYellow Fever—Angola (22 March 2016). Geneva: WHO, 2016. Available athttp://www.who.int/csr/don/22-march-2016-yellow-fever-angola/en/(accessed 24 March 2016).
5. McFarland JM,Baddour LM, et alNelson JE.Clin Infect Dis1997; 25:1143–1147.
6. Bendersky N,Carlet J, et alRicomme JL.Bull Soc Pathol Exot Filiales1980; 73:54–61.
7. Rodhain F,Hannoun C,Jousset FX,Ravisse P.Isolation of the yellow fever virus in Paris from 2 imported human cases.Bull Soc Pathol Exot Filiales1979; 72:411–415.
8. Bae HG,Drosten C, et alEmmerich P.J Clin Virol2005; 33:274–280.
9. Pang Z,Li A, et alLi J.PLoS ONE2014; 9:e95635.
10. Tamura K,Stecher G,Peterson D,Filipski A,Kumar S.MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.Mol Biol Evol2013; 30:2725–2729.
11. Kumar S,Stecher G,Tamura K.MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets.Mol Biol Evol2016; 33:1870–1874.
12. Alikhan NF,Petty NK,Ben Zakour NL,Beatson SA.BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons.BMC Genomics2011; 12:402.
13. Roukens AH,Visser LG.The risk of yellow fever in travellers.Ned Tijdschr Geneeskd2006 Aug 19; 150:1815–1820.
14. von Lindern JJ,Aroner S, et alBarrett ND.J Gen Virol2006; 87:895–907.
15. Gardner CL,Ryman KD.Yellow fever: a reemerging threat.Clin Lab Med2010; 30:237–260.
16. Quaresma JA,Barros VL, et alPagliari C.Trans R Soc Trop Med Hyg2007; 101:161–168.
17. Monath TP.Treatment of yellow fever.Antiviral Res2008; 78:116–124.
18. Mukhopadhyay S,Kuhn RJ,Rossmann MG.A structural perspective of the flavivirus life cycle.Nat Rev Microbiol2005; 3:13–22.
19. Pierson TC,Fremont DH,Kuhn RJ.Structural insights into the mechnisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development.Cell Host Microbe2008; 4:229–238.
20. Avirutnan P,Fuchs A, et alHauhart RE.J Exp Med2010; 207:793–806.
21. Agampodi SB,Wickramage K.Is there a risk of yellow fever virus transmission in South Asian countries with hyperendemic dengue?Biomed Res Int2013; 2013:905043.
22. Cathey JT,Marr JS.Yellow fever, Asia and the East African slave trade.Trans R Soc Trop Med Hyg2014; 108:252–257.
23. Lourenço-de-Oliveira R,Vazeille M.Bispo de Filippis AM, Failloux AB. Oral susceptibility to yellow fever virus of Aedes aegypti from Brazil.Mem Inst Oswaldo Cruz2002; 97:437–439.
24. Gubler DJ,Novak R,Mitchell CE, Arthropod vector competence epidemiological, genetic and biological considerations. In:Steiner W,Tabachnik W,Rai K,Narang S, (eds).Recent Developments in the Genetics of Insect Disease Vectors.Champaign Ill, USA: Stipes.1982,665.
25. Miller BR,Monath TP,Tabachnick WJ,Ezike VI.Epidemic yellow fever caused by an incompetent mosquito vector.Trop Med Parasitol1989; 40:396–399.